에 대한 최신 뉴스 ImmunityBio (NASDAQ:IBRX) 주식

IMMUNITYBIO INC

ImmunityBio

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

San,Jose,,California,Us,-,February,14,,2025:,Archer,Brand

Equities

Mid Cap

News

Movers

ACHR

DBRG

DGNX

IBRX

LUNR

OKLO

지난주 최고의 성과를 거둔 중형주는 다음과 같다. 풋락커, 아처 에비에이션, 디지털브릿지, 뉴스케일 파워, 디지넥스, 이뮤니티바이오, 오클로, 인튜이티브 머신스

풋락커·아처에비에이션 등 지난주 급등한 중형주 8종목 (5월 12~16일)

Quantum Computing

Trading Ideas

ALHC

BPMC

COMP

HEES

IONQ

MSFT

NVDA

OPCH

SEMR

1월 13일부터 17일까지 지난주에 최고의 실적을 거둔 중형주 8종목은 다음과 같다 .H&amp;E 이큅먼트 SEM러시 컴퍼스 블루프린트 얼라인먼트 옵션 케어 이뮤니티바이오 아이온큐

아이온큐, H&amp;E 이큅먼트, 이뮤니티바이오 등 지난주 급등한 중형주 (1월 13일~17일)

$BTC

IRTC

WULF

이들 10개 중형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 이뮤니티바이오(NASDAQ:IBRX)의 주식은 회사가 재발성 B-세포 비호지킨 림프종에 대한 CAR-NK 세포 치료제의 1상 임상 연구에서 첫 환자에게 투여했다고 발표한 후 49.86% 상승했다.

트럼프 미디어와 스트라이드는 지난주 최고 성과를 보여준 10개 중형주 중 일부 (10월 21일-10월 25일)

ImmunityBio Inc

Wells Fargo analyst Eric Luebchow maintains Dycom Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DY#NYSE">DY</a>) with a Overweight and raises the price target from $200 to $215.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Dycom Industries, Raises Price Target to $215

Truist Securities analyst Ki Bin Kim maintains EPR Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPR#NYSE">EPR</a>) with a Hold and raises the price target from $53 to $55.

Truist Securities Maintains Hold on EPR Props, Raises Price Target to $55

Truist Securities analyst David Macdonald maintains DaVita (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) with a Hold and lowers the price target from $170 to $164.

Truist Securities Maintains Hold on DaVita, Lowers Price Target to $164

Wells Fargo analyst Colin Langan maintains Visteon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VC#NASDAQ">VC</a>) with a Overweight and raises the price target from $96 to $101.

Wells Fargo Maintains Overweight on Visteon, Raises Price Target to $101

Truist Securities analyst Ki Bin Kim maintains CubeSmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBE#NYSE">CUBE</a>) with a Buy and raises the price target from $47 to $48.

CUBE

Truist Securities Maintains Buy on CubeSmart, Raises Price Target to $48

Tomahawk GCS, an AeroVironment ("AV") product line specializing in autonomous and intelligent multi-domain systems, has been awarded a $5.1 million contract to support the U.S. Army Rapid Capabilities and Critical Technologies Office (RCCTO) Human-Machine Integrated Formations (HMIF) rapid prototyping project. Following a rigorous selection process, AV's Tomahawk's Grip TA5 was selected as the Dismounted Common Controller (DCC) to significantly enhance human-machine teaming for battlefield operations.
The HMIF initiative, led by the U.S. Army RCCTO, is accelerating the integration of autonomous and robotic systems into formations to enhance situational awareness, lethality, and survivability. With its modular architecture and multi-platform compatibility, the Grip TA5 provides operators command-and-control of multiple robotic assets in real-time, enhancing mission adaptability and response speed.

Contracts

AVAV

AeroVironment's Tomahawk GCS Awarded $5.1M Contract To Support U.S. Army RCCTO Human-Machine Integrated Formations Rapid Prototyping Project

Government

Regulations

VRNS

Varonis Achieves FedRAMP Authorization For Native Data Security Platform

Moody's Ratings has officially stripped the U.S. of its final AAA credit score — the highest mark of financial credibility — sparking political uproar and media alarm, yet market analysts and economists widely believe it will have limited impact on <a href="https://www.benzinga.com/topic/expert-ideas">the broader financial system.</a>
<h3 class="wp-block-heading">What Did Moody's Decide About US Credit Rating?</h3>
Moody's cut the U.S. long-term sovereign credit rating to Aa1 from Aaa on Friday, citing sustained fiscal deficits, rising debt burdens and growing interest costs. 
The agency criticized "successive U.S. administrations and Congress" for failing to implement a credible debt reduction strategy.
This move aligns Moody's with Fitch Ratings, which downgraded the U.S. in August 2023, and S&amp;P Global Ratings, which cut the rating back in 2011. 
For the first time, all three major credit agencies have the U.S. rated below AAA.
<figure class="wp-block-table is-style-regular"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>S&amp;P</th>
<th>Moody&#8217;s</th>
<th>Fitch</th>
</tr>
<tr>
<th>AA+</th>
<th>Aa1</th>
<th>AA+</th>
</tr>
</thead>
</table>
</figure>
<h3 class="wp-block-heading">Do Markets Care This Time?</h3>
"This downgrade won't force anybody to do anything on Monday," said Jim Bianco of Bianco Research. 
He noted that after S&amp;P&#8217;s 2011 downgrade caused market disruption due to contract language requiring AAA-rated collateral, those rules were rewritten. "Now, these contracts reference ‘government securities,' not ratings," he said.
Bianco added, "So technically it didn't even change the US's overall credit rating because it was already split rated AA+. Now it's unanimous AA+. Nothing changed."
<h3 class="wp-block-heading">Debt Concerns Are Misguided</h3>
Macro analyst Alfonso Peccatiello also challenged the logic behind the downgrade. He indicated that U.S. debt in its own currency is not inherently dangerous. 
"Any government doing deficit spending and issuing bonds in its own currency—like the U.S.—isn't walking into an abyss of doom," Peccatiello said. "It's just choosing to stimulate the economy by printing money for the private sector."
Addressing concerns about the $1 trillion annual interest burden, he said this is simply money being transferred from the government to investors holding Treasury bonds. 
"For every dollar the U.S. pays in interest, there is an investor making that dollar," he said, framing it as a redistribution within the economy, not a red flag of insolvency.
Peccatiello explained that U.S. Treasuries continue functioning as high-quality liquid assets for banks under Basel regulations.
"The downgrade to AA+ wouldn't make any difference," he said, as government bonds rated between AAA and AA- carry the same 0% risk weighting under Basel's framework.
He said rising deficits only become problematic when they cause inflation or resource scarcity—not because of arbitrary credit score thresholds.
According to Peccatiello, long-term bond yields are already pricing in much of the fiscal outlook, making current levels—particularly 30-year Treasuries above 5.25%—increasingly attractive for accumulation.
<h3 class="wp-block-heading">More Politics Than Panic</h3>
Economist Mohamed El-Erian called the move "historic," but said it was unlikely to shake global markets. 
However, he added that the downgrade "amplifies the conversation about America&#8217;s political ability to address its fiscal deficit and debt trajectory."
El-Erian&#8217;s view mirrors market action: U.S. Treasuries remain the most trusted collateral globally, and their deep liquidity shields them from dramatic dislocations.
<h3 class="wp-block-heading">Political Reactions And The Trump Administration's Position</h3>
Treasury Secretary Scott Bessent, speaking on CNBC, called Moody's decision "a lagging indicator." 
He said, "We inherited a 6.7% deficit-to-GDP ratio, the highest when we weren't in a recession or at war. We are determined to bring spending down."
Bessent added that foreign capital flows remain robust. "Saudi Arabia, Qatar, and the UAE are pushing more and more money into the U.S., with 10-year investment plans," he said.
<h3 class="wp-block-heading">Wall Street Shakes On The Downgrade</h3>
Despite widespread commentary downplaying Moody's downgrade of U.S. debt, investors reacted defensively in Monday's premarket, with major equity futures sliding and high-growth tech stocks leading losses.
S&amp;P 500 futures fell 1%, while Nasdaq 100 contracts dropped 1.5%, signaling a risk-off tone ahead of the Wall Street open.
Among mega-cap stocks, the worst-hit names in premarket trading:
<ul class="wp-block-list">
<li>Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) declined 2%. </li>
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) dropped 4.4%.</li>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) declined 3.9%.</li>
<li>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) slipped 2.9%.</li>
<li>Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) lost 2.7%.</li>
<li>United Parcel Service Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) fell 2%.</li>
</ul>
The 30-year U.S. Treasury yield jumped 10 basis points to 5%, hitting its highest level since October 2023. The spike in yields reflects investor concerns over the long-term fiscal trajectory and a higher-for-longer interest rate environment.
The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>)—a popular proxy for long-dated U.S. bonds—fell 1.6% in premarket trading, continuing a trend of weakness in duration-sensitive assets.
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45489038/us-stocks-likely-to-open-lower-after-moodys-downgrade-bear-market-isnt-fully-recovered-yet-but-it-is-close-says-expert">US Stocks Likely To Open Lower After Moody&#8217;s Downgrade: &#8216;Bear Market Isn&#8217;t Fully Recovered Yet, But It Is Close,&#8217; Says Expert</a></li>
</ul>
Image: Shutterstock

Analyst Color

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

ETFs

AMZN

AVGO

PLTR

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

America's Credit Strength Just Got Cut Again: Should You Panic?

Truist Securities analyst Patrick Scholes maintains Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) with a Hold and lowers the price target from $30 to $27.

Truist Securities Maintains Hold on Carnival, Lowers Price Target to $27

TruBridge, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBRG#NASDAQ">TBRG</a>), a leading healthcare solutions company, today announced the integration of Microsoft Dragon Copilot with its electronic health record (EHR) solution. Collaboration between the two technologies will enhance care delivery, financial stability, and operational efficiency for thousands of hospitals and health systems across the country.
Microsoft Dragon Copilot will empower more than 18,000 TruBridge users with advanced, secure speech recognition and AI capabilities, designed to support the unique needs of community healthcare. This integration builds on TruBridge's advocacy for rural Americans as part of the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnews.microsoft.com%2F2024%2F03%2F11%2Fnew-consortium-of-healthcare-leaders-announces-formation-of-trustworthy-responsible-ai-network-train-making-safe-and-fair-ai-accessible-to-every-healthcare-organization%2F&amp;esheet=54255770&amp;newsitemid=20250519993778&amp;lan=en-US&amp;anchor=Trustworthy+%26amp%3B+Responsible+AI+Network+%28TRAIN%29&amp;index=1&amp;md5=b99d887ab50ec85e211d95d635d5138f">Trustworthy &amp; Responsible AI Network (TRAIN)</a>, announced with Microsoft and top healthcare providers, including Cleveland Clinic, at HIMSS 2024.

TBRG

TruBridge Integrates Microsoft Dragon Copilot With Its EHR Solution To Enhance Care Delivery, Financial Stability, And Efficiency

Wells Fargo analyst Colin Langan maintains TE Connectivity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) with a Equal-Weight and raises the price target from $148 to $156.

Wells Fargo Maintains Equal-Weight on TE Connectivity, Raises Price Target to $156

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">133.17</td>
<td align="right">0.08</td>
<td align="right">0.06</td>
<td>30.6K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">214.3500</td>
<td align="right">-3.320</td>
<td align="right">-1.53</td>
<td>12.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">231.4000</td>
<td align="right">-3.490</td>
<td align="right">-1.49</td>
<td>111.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">100.4400</td>
<td align="right">-1.340</td>
<td align="right">-1.32</td>
<td>3.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">142.3217</td>
<td align="right">-1.458</td>
<td align="right">-1.02</td>
<td>2.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">41.6300</td>
<td align="right">-0.380</td>
<td align="right">-0.91</td>
<td>1.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">81.5100</td>
<td align="right">-0.670</td>
<td align="right">-0.82</td>
<td>67.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">51.2500</td>
<td align="right">-0.340</td>
<td align="right">-0.66</td>
<td>585.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">84.9900</td>
<td align="right">-0.490</td>
<td align="right">-0.58</td>
<td>47.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">86.6300</td>
<td align="right">-0.420</td>
<td align="right">-0.49</td>
<td>1.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.8900</td>
<td align="right">-0.180</td>
<td align="right">-0.22</td>
<td>78.2K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For May 19, 2025

Mackenzie Realty Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKZR#NASDAQ">MKZR</a>) reported quarterly losses of $(0.47) per share. This is a 80.77 percent decrease over losses of $(0.26) per share from the same period last year. The company reported $4.27 million in sales this quarter. This is a 4.77 percent increase over sales of $4.08 million the same period last year.

Earnings

MKZR

Reported May 15, 2025: Mackenzie Realty Capital Q3 EPS $(0.47) Down From $(0.26) YoY, Sales $4.27M Up From $4.08M YoY

Truist Securities analyst Michael Lewis maintains Camden Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPT#NYSE">CPT</a>) with a Buy and raises the price target from $129 to $131.

Truist Securities Maintains Buy on Camden Prop Trust, Raises Price Target to $131

ALAB

Astera Labs Collaborates With NVIDIA To Provide Scale-Up Connectivity Solutions For New NVIDIA NVLink Fusion Ecosystem

Wells Fargo analyst Colin Langan maintains Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) with a Equal-Weight and raises the price target from $32 to $37.

Wells Fargo Maintains Equal-Weight on Magna International, Raises Price Target to $37

The Polish customs authority has seized over 5 metric tons of tires for Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) civilian aircraft due to transit through Russia, citing Western sanctions over Russia resulting from the invasion of Ukraine in February 2022.
What Happened: Poland's National Revenue Administration says that officers discovered civilian Boeing aircraft tires, instead of car and bus tires declared to the customs, during an inspection of a truck, Reuters reported on Monday.
"The sender of the goods was a company from Spain, and the recipient was from Azerbaijan." A statement by the authorities cited in the report says. The report also suggests that law enforcement has begun an investigation into the matter.
Boeing has suspended the supply of parts as well as technical support and maintenance for Russian airlines after the country invaded Ukraine in 2022, over three years ago.
Why It Matters: Boeing has been under scrutiny recently as the aircraft manufacturer<a href="https://www.benzinga.com/news/legal/25/05/45481977/boeing-may-reportedly-once-again-dodge-prosecution-over-737-max-crashes-victims-families-slam-dojs-potential-agreement-as-backroom-deal-dressed-up-as-a-legal-proceeding"> could dodge criminal charges</a> over two fatal crashes involving the Boeing 737 MAX in 2018 and 2019 that claimed over 346 lives, which has sparked outrage among the victims' families.
U.S. President Donald Trump also received a Boeing 747-8 Jumbo Jet from the Qatari Royal Family during his visit to the Middle East. The aircraft will serve as Trump's <a href="https://www.benzinga.com/25/05/45340930/trumps-400-million-boeing-jet-gift-from-qatar-sparks-outcry-from-larry-summers-peter-schiff-banana-republic-level-corruption">Air Force 1 replacement</a> until the end of his presidency.&nbsp;
Elsewhere, the CCP and Xi Jinping have<a href="https://www.benzinga.com/25/05/45368534/china-greenlights-boeing-jet-arrivals-again-as-90-day-tariff-pause-with-us-brings-relief"> lifted the halt </a>on Boeing imports for Chinese airlines as part of a 90-day tariff pause during the ongoing U.S.-China trade war.
Price Action: BA declined 1.61% in Pre-Market Trading, currently valued at $202.50, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45489193/trumps-former-vp-mike-pence-calls-qatari-jet-gift-a-bad-idea-urges-president-to-reject-400m-boeing-747">Trump&#8217;s Former VP Mike Pence Calls Qatari Royal Family&#8217;s Boeing Jet Gift A &#8216;Bad Idea,&#8217; Urges President To Reject $400 Million &#8216;Flying Palace&#8217;</a></li>
</ul>
Photo by BlueBarronPhoto via Shutterstock

Politics

Boeing Aircraft Tyres Confiscated By Poland Over Suspected Russia-Bound Shipment Amid Sanctions: Report

General

NMRK

Newmark Repurchases 10,969,523 From Commerce Secretary Lutnick As Lutnick Divests Interests Pursuant To US Government Ethics Rules

Wells Fargo analyst Colin Langan maintains Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) with a Equal-Weight and raises the price target from $89 to $100.

Wells Fargo Maintains Equal-Weight on Lear, Raises Price Target to $100

BGC Repurchases 16,452,850 From Commerce Secretary Lutnick As Lutnick Divests Interests Pursuant To US Government Ethics Rules

Press Releases

ImmunityBio to Host Investor Day

Legal

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors

ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial Launch

Pomerantz LLP and Holzer & Holzer, LLC Announce Pendency and Proposed Settlement of Class Action Involving Purchases of ImmunityBio, Inc. Securities

ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor

ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia

ImmunityBio to Showcase Advances for Bladder and Prostate Cancer at American Urological Association (AUA) Annual Meeting

Unmatched Long-Term Bladder Preservation for 36 Months in over 80 percent of Responders with ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC CIS and Papillary Disease Alone – Best in Disease and Best in Class with 5 Year Follow-Up

ImmunityBio Requests an Urgent Meeting With FDA to Address the Change in the Agency's Unambiguous Guidance on Jan 2025 to Submit a sBLA for NMIBC BCG Unresponsive Papillary Disease, Following an Inconsistent Refusal to File Letter on May 2, 2025

ImmunityBio Reports Doubled Net Revenue and 150% Unit Growth in Q1 2025, With Continued Strong Sales Momentum in First Quarter since J-code

DRVN

WOLF

Ascentage Pharma Group International - American Depository Shares

Ascentage Pharma Group

Arcellx

Akero Therapeutics

Alvotech

Apogee Therapeutics

Apellis Pharmaceuticals, Inc. - Common Stock

Apellis Pharmaceuticals

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharma

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Catalyst Pharmaceuticals, Inc. - Common Stock

Catalyst Pharmaceuticals

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals

Denali Therapeutics

Amicus Therapeutics

Immunovant

Mirum Pharmaceuticals, Inc. - common stock

Mirum Pharmaceuticals

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

Metsera

NewAmsterdam Pharma Company N.V. - Ordinary Shares

NewAmsterdam Pharma Co

Protagonist Therapeutics, Inc. - Common Stock

Protagonist Therapeutics

Ultragenyx Pharmaceutical Inc. - Common Stock

Ultragenyx Pharmaceutical

Scholar Rock Holding Corporation - Common Stock

Scholar Rock Holding

SpringWorks Therapeutics, Inc. - common stock

SpringWorks Therapeutics

Vericel

Veracyte

Viking Therapeutics

Zai Lab Limited - American Depositary Shares

Zai Lab

HC Wainwright & Co.

D. Boral Capital

BTIG

EF Hutton

지난주 최고의 성과를 거둔 중형주는 다음과 같다.
<ol class="wp-block-list">
<li>풋락커(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) 주가는 약 98.58% 급등했다, 딕스 스포팅 굿즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>)가 약 24억 달러의 자본가치로 회사를 인수하기로 합의한 이후였다. 또한 회사는 <a href="https://www.benzinga.com//node/45435748" target="_blank" rel="noreferrer noopener">1분기 예비 실적</a>을 발표했으며 여러 애널리스트가 <a href="https://www.benzinga.com/quote/fl/analyst-ratings" target="_blank" rel="noreferrer noopener">목표주가를 상향 조정</a>했다.</li>
<li>아처 에비에이션 항공(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) 주가는 50.96% 상승했다, 회사가 예상보다 나은 주당순이익(EPS) 결과를 보고하고 <a href="https://www.benzinga.com//node/45443360" target="_blank" rel="noreferrer noopener">LA28 올림픽 및 패럴림픽 게임</a>의 공식 에어택시(air taxi) 제공업체가 되는 독점 파트너십을 발표했기 때문이다.</li>
<li>디지털브리지 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBRG#NYSE">DBRG</a>) 주가는 38.63% 증가했다. 트레이더들은 &#8217;26North&#8217;가 회사를 인수하기 위한 협상을 진행 중이라는 확인되지 않은 인수 소문을 돌리고 있다.</li>
<li>뉴스케일 파워(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) 주가는 38.51% 상승했으며, 이는 <a href="https://www.benzinga.com//node/45383335" target="_blank" rel="noreferrer noopener">1분기 실적 발표</a> 이후 올랐다.</li>
<li>디지넥스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) 주가는 38.37% 급등했다.</li>
<li>이뮤니티바이오(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) 주가는 회사가 <a href="https://www.benzinga.com//node/45343007" target="_blank" rel="noreferrer noopener">예상보다 나은 실적</a>을보고한 이후 37.20% 상승했다.</li>
<li>오클로(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) 주가는 전년 대비 <a href="https://www.benzinga.com//node/45472603" target="_blank" rel="noreferrer noopener">1분기 실적 개선</a>을 보고한 이후 34.28% 상승했다.</li>
<li>인튜이티브 머신스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) 주가는 회사가 <a href="https://www.benzinga.com//node/45400804" target="_blank" rel="noreferrer noopener">예상치를 웃도는 중간값으로 FY25 매출 가이던스</a>를 발표한 이후 33.77% 상승했다.</li>
</ol>
사진 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

1월 13일부터 17일까지 지난주에 최고의 실적을 거둔 중형주 8종목은 다음과 같다.
<ol>
<li>H&amp;E 이큅먼트 서비시스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEES#NASDAQ">HEES</a>): 유나이티드 렌탈스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>)가 약 <a href="https://www.benzinga.com//node/42974291" target="_blank" rel="noreferrer noopener">48억 달러에 H&amp;E 이큅먼트를 인수하겠다고 발표</a>한 후 100.59% 급등했다. UBS는 H&amp;E 이큅먼트 투자의견을 매수에서 중립으로 하향 조정하고, 목표주가를 <a href="https://www.benzinga.com/quote/HEES/analyst-ratings" target="_blank" rel="noreferrer noopener">60달러에서 92달러로 상향 조정</a>했다.</li>
<li>SEM러시 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMR#NYSE">SEMR</a>): 미국 소비자물가지수(CPI) 데이터가 예상과 일치하고 근원 CPI가 예상보다 적게 상승하면서 전체 시장이 강세를 보인 후 36.17% 상승했다. 또한 모건스탠리는 회사에 대한 투자의견을 중립에서 비중확대로 상향 조정하고, <a href="https://www.benzinga.com/quote/semr/analyst-ratings" target="_blank" rel="noreferrer noopener">목표주가를 17달러에서 20달러로 상향 조정</a>했다.</li>
<li>컴퍼스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COMP#NYSE">COMP</a>): 회사가 <a href="https://www.benzinga.com//node/42997946" target="_blank" rel="noreferrer noopener">4분기 및 2024회계연도 가이던스를 상향 조정</a>한 후 26.36% 상승했다.</li>
<li>블루프린트 메디슨스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>): 회사가 <a href="https://www.benzinga.com//node/42935745" target="_blank" rel="noreferrer noopener">2024 회계연도 AYVAKIT 매출 실적이 전년 대비 증가</a>했다고 발표한 후 25.87% 상승했다.</li>
<li>얼라인먼트 헬스케어(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>): 지난주 22.73% 상승했다.</li>
<li>옵션 케어 헬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPCH#NASDAQ">OPCH</a>): 회사가 5억 달러 규모의 새로운 자사주매입 프로그램을 승인하고, 2024회계연도 조정 EPS 가이던스를 예상치를 상회한다고 발표한 후 21.55% 상승했다. 바링턴 리서치(Barrington Research)는 회사에 대한 시장수익률 상회 의견을 유지하고, <a href="https://www.benzinga.com/quote/OPCH/analyst-ratings" target="_blank" rel="noreferrer noopener">목표주가를 32달러에서 33달러로 상향 조정</a>했다.</li>
<li>이뮤니티바이오(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>):ㅜ 회사가 진행 중인 미 식품의약국(FDA)과 논의에 대한 업데이트를 제공한 후 21.49% 상승했다. 논의된 세 가지 분야는 비근육 침윤성 방광암(NMIBC) 및 <a href="https://www.benzinga.com//node/43038889" target="_blank" rel="noreferrer noopener">비소세포폐암(NSCLC)</a>이다.</li>
<li>아이온큐(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>): 마이크로소프트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)가 비즈니스 고객에게 &#8220;퀀텀 레디&#8221;를 하라고 발언한 후 20.29% 급등했다. 또한 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)가 <a href="https://www.benzinga.com/25/01/43011494/whats-going-on-with-ionq-stock-today" target="_blank" rel="noreferrer noopener">첫 번째 &#8216;퀀텀 데이&#8217; 이벤트</a>를 발표했다.</li>
</ol>
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/%EB%A7%88%EC%9D%B4%ED%81%AC%EB%A1%9C%EC%8A%A4%ED%8A%B8%EB%A0%88%ED%8B%B0%EC%A7%80-%EC%86%8C%ED%8C%8C%EC%9D%B4-%ED%85%8C%ED%81%AC%EB%86%80%EB%A1%9C%EC%A7%80%EC%8A%A4-%EC%B9%B4%EB%B0%94%EB%82%98/">마이크로스트레티지, 소파이 테크놀로지스, 카바나 등 지난주 급등한 대형주 (1월 13일~1월 17일)</a>
이미지 출처: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

아이온큐, H&E 이큅먼트, 이뮤니티바이오 등 지난주 급등한 중형주 (1월 13일~17일)

이들 10개 중형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 이뮤니티바이오(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>)의 주식은 회사가 재발성 <a href="https://www.benzinga.com//node/41516867" target="_blank" rel="noreferrer noopener">B-세포 비호지킨 림프종</a>에 대한 CAR-NK 세포 치료제의 1상 임상 연구에서 첫 환자에게 투여했다고 발표한 후 49.86% 상승했다.
2. 스트라이드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>)의 주식은 회사가 1분기 실적이 예상보다 좋게 나타났고, 2025 회계연도 및 2분기 <a href="https://www.benzinga.com//node/41487340" target="_blank" rel="noreferrer noopener">매출 가이던스도 예상치를 상회</a>했다고 발표한 후 41.43% 급등했다. 애널리스트들이 <a href="https://www.benzinga.com/quote/lrn/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 목표</a>를 올렸다.
3. 퓨어사이클 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>)의 <a href="https://www.benzinga.com//node/41409452" target="_blank" rel="noreferrer noopener">주식은 32.21% 상승</a>했다.
4. 트럼프 미디어 앤 테크놀로지 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>)의 주식은 지난주에 31.68% 상승했다. 이 주식은 다가오는 미국 선거를 앞두고 변동성을 보였다.
5. 지커 인텔리전트 테크놀러지(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZK#NYSE">ZK</a>)의 주식은 29.31% 상승했다. 여러 미국 상장 중국 주식들이 인민은행이 <a href="https://www.benzinga.com//node/41547149" target="_blank" rel="noreferrer noopener">7,000억 위안</a> (약 983억 6천만 달러)를 은행 시스템에 주입하고 금리를 2.0%로 유지했다고 발표한 후 상승했다.
6. 아이온큐(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>)의 주식은 27.52% 상승했다.
7. 허크 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRI#NYSE">HRI</a>)의 주식은 회사가 3분기 매출 실적이 예상보다 좋았고 2024 회계연도 장비 <a href="https://www.benzinga.com//node/41455862" target="_blank" rel="noreferrer noopener">임대 매출 성장 전망을 상향 조정</a>했다고 발표한 후 21.76% 상승했다.
8. 테라울프(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>)의 주식은 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) 가격 상승으로 18.59% 상승했다. 이 회사는 또한 4억 2,500만 달러를 전환사채로 조달할 것을 제안했다.
9. 아이리듬 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/41462205" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">지오(Zio) AT 기기</a>의 이전 설계 변경과 관련된 510(k) 제출에 대해 FDA 승인을 받았다고 발표한 후 주가가 20.76% 상승했다.
10. 셀레스티카(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>)의 주식은 회사가 3분기 실적이 예상보다 좋았고 4분기 매출 가이던스를 예상치를 상회한다고 발표한 후 19.99% 상승했다. 여러 애널리스트들이 <a href="https://www.benzinga.com//node/41523564" target="_blank" rel="noreferrer noopener">주가 목표</a>를 올렸다.
또한 읽어보기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%ED%85%8C%EC%8A%AC%EB%9D%BC%EC%99%80-%EB%A6%AC-%EC%98%A4%ED%86%A0%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%97%AC%EC%A4%80-10%EA%B0%9C-%EB%8C%80/" target="_blank" rel="noopener">테슬라와 리 오토는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (10월 21일-10월 25일)</a></li>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%A0%9C%EB%89%B4%EC%9D%B8-%ED%8C%8C%EC%B8%A0-%EB%B0%8F-%ED%83%91%EB%B9%8C%EB%93%9C%EA%B0%80-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EC%95%85%EC%9D%98-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%9D%B8-10/" target="_blank" rel="noopener">제뉴인 파츠 및 탑빌드가 지난주 최악의 성과를 보인 10개 대형주 중 일부 (10월 21일-10월 25일)</a></li>
</ul>
Photo via Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
<ol>
<li>빌리빌리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>)의 주가는 지난주 &#8216;산구오: 무딩티엔샤(San Guo: Mou Ding Tian Xia)&#8217; 발표 이후 23.32% 상승했다. 또한 JP모건 애널리스트 다니엘 첸(Daniel Chen)은 중국의 빌리빌리를 중립에서 비중확대로 상향 조정하고 <a href="https://www.benzinga.com//node/39418621" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">21</a>달러 가격 목표를 발표했다.</li>
<li>이뮤니티바이오(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>)의 주가는 안크티바(ANKTIVA)가 여러 주에 걸쳐 <a href="https://www.benzinga.com//node/39417764" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">첫 번째 상용 투여량</a>을 투여한 보험 적용 범위를 발표한 이후 지속적인 강세로 22.36% 상승했다.</li>
<li>사솔(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>)은 회사가 법원에서 회사와 토탈에너지스 SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) 마켓팅에 유리한 판결을 내렸다고 발표한 후 주가는 20.89% 상승했다. 또한 손해배상금으로 38.9억 랜드, <a href="https://www.benzinga.com//node/39412202" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">이자로 약 2,300만 랜드</a>를 받았다.</li>
<li>지난주 올리즈 바겐 아울렛 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>)의 주식은 JP모건이 중립에서 <a href="https://www.benzinga.com/quote/OLLI/analyst-ratings">비중확대</a>로 평가를 올린 이후 15.25% 상승했다.</li>
<li>인트라-셀룰러 테라피스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>)는 회사가 루마테페론을 주요 우울 장애 환자를 위한 보조 요법으로 평가하고 <a href="https://www.benzinga.com//node/39382029" target="_blank" rel="noreferrer noopener">1차 및 주요 2차 평가변수를 충족</a>시키는 두 번째 3상 시험의 톱라인 결과를 발표한 후 주가는 13.18% 상승했다.      shares advanced 12.06% on overall strength in chip stocks. Also, B. Riley Securities analyst <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings" target="_blank" rel="noopener">raised the price forecast</a> on the stock from $45 to $50.</li>
<li>앰코 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>)는 전반적인 칩주 강세로 주가는 12.06% 상승했다. 또한 B. 라일리 증권(B. Riley Securities)의 분석가는 주식 가격 <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings" target="_blank" rel="noopener">예측</a>을 45달러에서 50달러로 높였다.</li>
<li>아이리듬 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>)는 회사가 이전에 공개한 <a href="https://www.benzinga.com//node/39411935" target="_blank" rel="noreferrer noopener">제조 자동화 계획</a>의 초기 단계를 시작한 후 기업의 이정표에 도달했다고 발표한 후 주가는 11.53% 증가했다.</li>
<li>로켓 랩 USA(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>)는 주가는 <a href="https://www.benzinga.com//node/39429411" target="_blank" rel="noreferrer noopener">일본 기업 신스펙티브(Synspective)</a>와 도쿄에서 10개 제품 출시 계약을 체결한 후 11.32% 상승했다.</li>
<li>브레드 파이낸셜 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>)는 에버코어 ISI 그룹(Evercore ISI Group)이 이 주식을 언더퍼폼(Underperform)에서 인-라인(In-Line)으로 평가를 올리고 목표 주가를 42달러에서 45달러로 <a href="https://www.benzinga.com/quote/BFH/analyst-ratings" target="_blank" rel="noreferrer noopener">상향 조정한 </a>이후 10.81% 상승했다. 또한 또한 RBC 캐피털은 해당 주식에 대해 섹터 퍼폼(Sector Perform) 등급을 유지하고 목표 주가를 38달러에서 45달러로 높였다.</li>
<li>BRF S.A.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRFS#NYSE">BRFS</a>)의 주식은 10.69% 상승했다.</li>
</ol>
위키미디어 커먼즈를 통한 사진
기사 읽기: <a href="https://kr.benzinga.com/news/%ea%b2%8c%ec%9e%84%ec%8a%a4%ed%83%91%ea%b3%bc-%ec%9e%90%eb%b9%8c%ec%9d%80-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ec%95%85%ec%9d%98-%ec%84%b1%ea%b3%bc%eb%a5%bc-%eb%b3%b4%ec%9d%b8-10%ea%b0%9c%ec%9d%98/" target="_blank" rel="noopener">게임스탑과 자빌은 지난주 최악의 성과를 보인 10개의 대형주 중 일부 (6월 16일-6월 22일)</a>

Comments

ImmunityBio

뉴스

에 대한 최신 뉴스 ImmunityBio (NASDAQ:IBRX) 주식

일요일, 5월 18, 2025

월요일, 1월 20, 2025

월요일, 10월 28, 2024

월요일, 6월 24, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌